Japanese Pearl Tree (Styphnolobium japonicum): An Exploration of Its Health Benefits.

IF 2.1 4区 医学 Q3 CHEMISTRY, MEDICINAL
Planta medica Pub Date : 2026-08-01 Epub Date: 2026-04-09 DOI:10.1055/a-2817-4235
Magdalena Paczkowska-Walendowska, Zuzanna Rybarczyk, Maria Raniszewska, Elżbieta Studzińska-Sroka, Judyta Cielecka-Piontek
{"title":"Japanese Pearl Tree (Styphnolobium japonicum): An Exploration of Its Health Benefits.","authors":"Magdalena Paczkowska-Walendowska, Zuzanna Rybarczyk, Maria Raniszewska, Elżbieta Studzińska-Sroka, Judyta Cielecka-Piontek","doi":"10.1055/a-2817-4235","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>The Japanese pearl tree (<i>Styphnolobium japonicum</i>), an ornamental species native to East Asia, has long been valued in traditional Chinese medicine and is now gaining renewed attention for its multifaceted pharmacological potential. This review synthesizes the current knowledge of its bioactive compounds, particularly flavonoids such as genistein, rutoside, quercetin, and sophoricoside, and their broad-spectrum biological activities, including antioxidant, anti-inflammatory, antimicrobial, neuroprotective, and wound-healing effects. These phytochemicals contribute to protective mechanisms against oxidative stress, skin photoaging, osteoporosis, cardiovascular dysfunction, and metabolic disorders such as diabetes and obesity. Emerging evidence also supports their role in managing neurodegenerative and inflammatory diseases, alopecia, and postmenopausal symptoms. Despite its promise, the clinical translation of <i>S. japonicum</i> remains limited by gaps in safety, pharmacokinetic characterization, and standardized extraction protocols. Looking ahead, integrative approaches combining phytochemistry, pharmacogenomics, and advanced biotechnology are expected to unlock its full therapeutic potential. By bridging traditional use with precision medicine and sustainable bioprocessing, <i>S. japonicum</i> stands as a prospective source of next-generation plant-based therapeutics for modern healthcare.</p>","PeriodicalId":20127,"journal":{"name":"Planta medica","volume":" ","pages":"996-1007"},"PeriodicalIF":2.1000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Planta medica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2817-4235","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: The Japanese pearl tree (Styphnolobium japonicum), an ornamental species native to East Asia, has long been valued in traditional Chinese medicine and is now gaining renewed attention for its multifaceted pharmacological potential. This review synthesizes the current knowledge of its bioactive compounds, particularly flavonoids such as genistein, rutoside, quercetin, and sophoricoside, and their broad-spectrum biological activities, including antioxidant, anti-inflammatory, antimicrobial, neuroprotective, and wound-healing effects. These phytochemicals contribute to protective mechanisms against oxidative stress, skin photoaging, osteoporosis, cardiovascular dysfunction, and metabolic disorders such as diabetes and obesity. Emerging evidence also supports their role in managing neurodegenerative and inflammatory diseases, alopecia, and postmenopausal symptoms. Despite its promise, the clinical translation of S. japonicum remains limited by gaps in safety, pharmacokinetic characterization, and standardized extraction protocols. Looking ahead, integrative approaches combining phytochemistry, pharmacogenomics, and advanced biotechnology are expected to unlock its full therapeutic potential. By bridging traditional use with precision medicine and sustainable bioprocessing, S. japonicum stands as a prospective source of next-generation plant-based therapeutics for modern healthcare.

日本珍珠树(Styphnolobium japonicum):其保健功效的探索。
日本珍珠树(Styphnolobium japonicum)是一种原产于东亚的观赏树种,长期以来一直受到中国传统医学的重视,现在因其多方面的药理潜力而重新受到关注。本文综述了其生物活性成分,特别是黄酮类化合物,如染料木黄酮、芦桃苷、槲皮素和槐糖苷,以及它们的广谱生物活性,包括抗氧化、抗炎、抗菌、神经保护和伤口愈合作用。这些植物化学物质有助于防止氧化应激、皮肤光老化、骨质疏松、心血管功能障碍和代谢紊乱,如糖尿病和肥胖。新出现的证据也支持它们在治疗神经退行性疾病和炎症性疾病、脱发和绝经后症状方面的作用。尽管有希望,日本血吸虫的临床转化仍然受到安全性,药代动力学表征和标准化提取方案的差距的限制。展望未来,结合植物化学、药物基因组学和先进生物技术的综合方法有望释放其全部治疗潜力。通过将传统用途与精准医学和可持续生物加工相结合,日本参作为现代医疗保健下一代植物性疗法的潜在来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Planta medica
Planta medica 医学-药学
CiteScore
5.10
自引率
3.70%
发文量
101
审稿时长
1.8 months
期刊介绍: Planta Medica is one of the leading international journals in the field of natural products – including marine organisms, fungi as well as micro-organisms – and medicinal plants. Planta Medica accepts original research papers, reviews, minireviews and perspectives from researchers worldwide. The journal publishes 18 issues per year. The following areas of medicinal plants and natural product research are covered: -Biological and Pharmacological Activities -Natural Product Chemistry & Analytical Studies -Pharmacokinetic Investigations -Formulation and Delivery Systems of Natural Products. The journal explicitly encourages the submission of chemically characterized extracts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书